{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:49:25Z","timestamp":1786981765627,"version":"build-2736575974"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2018,8,21]],"date-time":"2018-08-21T00:00:00Z","timestamp":1534809600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2018,8,21]],"date-time":"2018-08-21T00:00:00Z","timestamp":1534809600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["K01DK114334"],"award-info":[{"award-number":["K01DK114334"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011354","name":"Comprehensive Cancer Center, University of Michigan","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100011354","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1007\/s11255-018-1970-2","type":"journal-article","created":{"date-parts":[[2018,8,21]],"date-time":"2018-08-21T10:52:57Z","timestamp":1534848777000},"page":"1745-1751","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Cancer survivorship issues with radiation and hemorrhagic cystitis in gynecological malignancies"],"prefix":"10.1007","volume":"50","author":[{"given":"Bernadette M. M.","family":"Zwaans","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura E.","family":"Lamb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Bartolone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heinz E.","family":"Nicolai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael B.","family":"Chancellor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stangel-W\u00f3jcikiewicz","family":"Klaudia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,8,21]]},"reference":[{"key":"1970_CR1","volume-title":"Cancer facts & figs","author":"American Cancer Society","year":"2018","unstructured":"American Cancer Society (2018) Cancer facts & figs. American Cancer Society, Atlanta"},{"key":"1970_CR2","volume-title":"Hemorrhagic cystitis eMedicine","author":"JS Basler","year":"2009","unstructured":"Basler JS (2009) Hemorrhagic cystitis eMedicine. Medscape, Santa Fe"},{"issue":"7","key":"1970_CR3","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1111\/bju.12291","volume":"112","author":"H Payne","year":"2013","unstructured":"Payne H, Adamson A, Bahl A, Borwell J, Dodds D, Heath C, Huddart R, McMenemin R, Patel P, Peters JL, Thompson A (2013) Chemical- and radiation-induced haemorrhagic cystitis: current treatments and challenges. BJU Int 112(7):885\u2013897. \n                    https:\/\/doi.org\/10.1111\/bju.12291","journal-title":"BJU Int"},{"key":"1970_CR4","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.urology.2016.07.030","volume":"100","author":"EL Matz","year":"2017","unstructured":"Matz EL, Hsieh MH (2017) Review of advances in uroprotective agents for cyclophosphamide- and ifosfamide-induced hemorrhagic cystitis. Urology 100:16\u201319. \n                    https:\/\/doi.org\/10.1016\/j.urology.2016.07.030","journal-title":"Urology"},{"key":"1970_CR5","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.gore.2018.04.001","volume":"24","author":"R Isono-Nakata","year":"2018","unstructured":"Isono-Nakata R, Tsubamoto H, Ueda T, Inoue K, Shibahara H (2018) Bevacizumab with metronomic chemotherapy of low-dose oral cyclophosphamide in recurrent cervical cancer: four cases. Gynecol Oncol Rep 24:57\u201360. \n                    https:\/\/doi.org\/10.1016\/j.gore.2018.04.001","journal-title":"Gynecol Oncol Rep"},{"issue":"6","key":"1970_CR6","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.3892\/mco.2017.1457","volume":"7","author":"LW de Boo","year":"2017","unstructured":"de Boo LW, Vulink AJE, Bos M (2017) Metronomic cyclophosphamide-induced long-term remission after recurrent high-grade serous ovarian cancer: a case study. Mol Clin Oncol 7(6):1130\u20131134. \n                    https:\/\/doi.org\/10.3892\/mco.2017.1457","journal-title":"Mol Clin Oncol"},{"key":"1970_CR7","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.urology.2015.11.001","volume":"88","author":"BM Zwaans","year":"2016","unstructured":"Zwaans BM, Chancellor MB, Lamb LE (2016) Modeling and treatment of radiation cystitis. Urology 88:14\u201321. \n                    https:\/\/doi.org\/10.1016\/j.urology.2015.11.001","journal-title":"Urology"},{"issue":"2","key":"1970_CR8","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3909\/riu0700","volume":"18","author":"BM Zwaans","year":"2016","unstructured":"Zwaans BM, Nicolai HG, Chancellor MB, Lamb LE (2016) Challenges and opportunities in radiation-induced hemorrhagic cystitis. Rev Urol 18(2):57\u201365. \n                    https:\/\/doi.org\/10.3909\/riu0700","journal-title":"Rev Urol"},{"issue":"4","key":"1970_CR9","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.jpurol.2009.02.199","volume":"5","author":"DB Decker","year":"2009","unstructured":"Decker DB, Karam JA, Wilcox DT (2009) Pediatric hemorrhagic cystitis. J Pediatr Urol 5(4):254\u2013264. \n                    https:\/\/doi.org\/10.1016\/j.jpurol.2009.02.199","journal-title":"J Pediatr Urol"},{"issue":"4","key":"1970_CR10","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1002\/cncr.20444","volume":"101","author":"G Delaney","year":"2004","unstructured":"Delaney G, Jacob S, Barton M (2004) Estimation of an optimal radiotherapy utilization rate for gynecologic carcinoma: part I\u2013malignancies of the cervix, ovary, vagina and vulva. Cancer 101(4):671\u2013681. \n                    https:\/\/doi.org\/10.1002\/cncr.20444","journal-title":"Cancer"},{"issue":"4","key":"1970_CR11","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1002\/cncr.20445","volume":"101","author":"G Delaney","year":"2004","unstructured":"Delaney G, Jacob S, Barton M (2004) Estimation of an optimal radiotherapy utilization rate for gynecologic carcinoma: part II\u2013carcinoma of the endometrium. Cancer 101(4):682\u2013692. \n                    https:\/\/doi.org\/10.1002\/cncr.20445","journal-title":"Cancer"},{"issue":"3","key":"1970_CR12","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1097\/COC.0000000000000016","volume":"38","author":"WM Mendenhall","year":"2015","unstructured":"Mendenhall WM, Henderson RH, Costa JA, Hoppe BS, Dagan R, Bryant CM, Nichols RC, Williams CR, Harris SE, Mendenhall NP (2015) Hemorrhagic radiation cystitis. Am J Clin Oncol 38(3):331\u2013336. \n                    https:\/\/doi.org\/10.1097\/COC.0000000000000016","journal-title":"Am J Clin Oncol"},{"issue":"3","key":"1970_CR13","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/0167-8140(93)90260-F","volume":"26","author":"D Chassagne","year":"1993","unstructured":"Chassagne D, Sismondi P, Horiot JC, Sinistrero G, Bey P, Zola P, Pernot M, Gerbaulet A, Kunkler I, Michel G (1993) A glossary for reporting complications of treatment in gynecological cancers. Radiother Oncol 26(3):195\u2013202","journal-title":"Radiother Oncol"},{"issue":"3","key":"1970_CR14","first-page":"108","volume":"15","author":"F Suriano","year":"2013","unstructured":"Suriano F, Altobelli E, Sergi F, Buscarini M (2013) Bladder cancer after radiotherapy for prostate cancer. Rev Urol 15(3):108\u2013112","journal-title":"Rev Urol"},{"issue":"suppl_4","key":"1970_CR15","doi-asserted-by":"publisher","first-page":"iv72","DOI":"10.1093\/annonc\/mdx220","volume":"28","author":"C Marth","year":"2017","unstructured":"Marth C, Landoni F, Mahner S, McCormack M, Gonzalez-Martin A, Colombo N (2017) Cervical cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 28(suppl_4):iv72\u2013iv83. \n                    https:\/\/doi.org\/10.1093\/annonc\/mdx220","journal-title":"Ann Oncol"},{"issue":"4","key":"1970_CR16","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/S0360-3016(99)00111-X","volume":"44","author":"CA Perez","year":"1999","unstructured":"Perez CA, Grigsby PW, Lockett MA, Chao KS, Williamson J (1999) Radiation therapy morbidity in carcinoma of the uterine cervix: dosimetric and clinical correlation. Int J Radiat Oncol Biol Phys 44(4):855\u2013866","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"Suppl 6","key":"1970_CR17","doi-asserted-by":"publisher","first-page":"633638","DOI":"10.1093\/annonc\/mdt353","volume":"24","author":"N Colombo","year":"2013","unstructured":"Colombo N, Preti E, Landoni F, Carinelli S, Colombo A, Marini C, Sessa C (2013) Endometrial cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 24(Suppl 6):633\u2013638. \n                    https:\/\/doi.org\/10.1093\/annonc\/mdt353","journal-title":"Ann Oncol"},{"issue":"9717","key":"1970_CR18","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/s0140-6736(09)62163-2","volume":"375","author":"RA Nout","year":"2010","unstructured":"Nout RA, Smit VT, Putter H, Jurgenliemk-Schulz IM, Jobsen JJ, Lutgens LC, van der Steen-Banasik EM, Mens JW, Slot A, Kroese MC, van Bunningen BN, Ansink AC, van Putten WL, Creutzberg CL (2010) Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial. Lancet 375(9717):816\u2013823. \n                    https:\/\/doi.org\/10.1016\/s0140-6736(09)62163-2","journal-title":"Lancet"},{"key":"1970_CR19","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001773","author":"AS Denton","year":"2002","unstructured":"Denton AS, Clarke NW, Maher EJ (2002) Non-surgical interventions for late radiation cystitis in patients who have received radical radiotherapy to the pelvis. Cochrane Database Syst Rev. \n                    https:\/\/doi.org\/10.1002\/14651858.CD001773","journal-title":"Cochrane Database Syst Rev"},{"issue":"3 Pt 1","key":"1970_CR20","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1097\/00005392-199909010-00002","volume":"162","author":"M Capelli-Schellpfeffer","year":"1999","unstructured":"Capelli-Schellpfeffer M, Gerber GS (1999) The use of hyperbaric oxygen in urology. J Urol 162(3 Pt 1):647\u2013654","journal-title":"J Urol"},{"key":"1970_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2015.11.001","author":"BM Zwaans","year":"2015","unstructured":"Zwaans BM, Chancellor MB, Lamb LE (2015) Modeling and treatment of radiation cystitis. Urology. \n                    https:\/\/doi.org\/10.1016\/j.urology.2015.11.001","journal-title":"Urology"},{"issue":"4","key":"1970_CR22","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.urology.2004.10.050","volume":"65","author":"KT Chong","year":"2005","unstructured":"Chong KT, Hampson NB, Corman JM (2005) Early hyperbaric oxygen therapy improves outcome for radiation-induced hemorrhagic cystitis. Urology 65(4):649\u2013653. \n                    https:\/\/doi.org\/10.1016\/j.urology.2004.10.050","journal-title":"Urology"},{"issue":"3","key":"1970_CR23","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/j.ijrobp.2011.12.056","volume":"84","author":"C Oliai","year":"2012","unstructured":"Oliai C, Fisher B, Jani A, Wong M, Poli J, Brady LW, Komarnicky LT (2012) Hyperbaric oxygen therapy for radiation-induced cystitis and proctitis. Int J Radiat Oncol Biol Phys 84(3):733\u2013740. \n                    https:\/\/doi.org\/10.1016\/j.ijrobp.2011.12.056","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"9","key":"1970_CR24","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1046\/j.1464-410x.2000.00900.x","volume":"86","author":"SK Choong","year":"2000","unstructured":"Choong SK, Walkden M, Kirby R (2000) The management of intractable haematuria. BJU Int 86(9):951\u2013959","journal-title":"BJU Int"},{"issue":"2","key":"1970_CR25","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1006\/gyno.1994.1278","volume":"55","author":"C Levenback","year":"1994","unstructured":"Levenback C, Eifel PJ, Burke TW, Morris M, Gershenson DM (1994) Hemorrhagic cystitis following radiotherapy for stage Ib cancer of the cervix. Gynecol Oncol 55(2):206\u2013210. \n                    https:\/\/doi.org\/10.1006\/gyno.1994.1278","journal-title":"Gynecol Oncol"},{"issue":"2","key":"1970_CR26","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/S0022-5347(17)36051-2","volume":"149","author":"AK Goswami","year":"1993","unstructured":"Goswami AK, Mahajan RK, Nath R, Sharma SK (1993) How safe is 1% alum irrigation in controlling intractable vesical hemorrhage? J Urol 149(2):264\u2013267","journal-title":"J Urol"},{"issue":"3","key":"1970_CR27","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/S0002-9629(15)40610-X","volume":"318","author":"KR Phelps","year":"1999","unstructured":"Phelps KR, Naylor K, Brien TP, Wilbur H, Haqqie SS (1999) Encephalopathy after bladder irrigation with alum: case report and literature review. Am J Med Sci 318(3):181\u2013185","journal-title":"Am J Med Sci"},{"issue":"3","key":"1970_CR28","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/0090-4295(92)90479-G","volume":"40","author":"I Singh","year":"1992","unstructured":"Singh I, Laungani GB (1992) Intravesical epsilon aminocaproic acid in management of intractable bladder hemorrhage. Urology 40(3):227\u2013229","journal-title":"Urology"},{"issue":"5","key":"1970_CR29","first-page":"421","volume":"80","author":"D Laszlo","year":"1995","unstructured":"Laszlo D, Bosi A, Guidi S, Saccardi R, Vannucchi AM, Lombardini L, Longo G, Fanci R, Azzi A, De Santis R et al (1995) Prostaglandin E2 bladder instillation for the treatment of hemorrhagic cystitis after allogeneic bone marrow transplantation. Haematologica 80(5):421\u2013425","journal-title":"Haematologica"},{"issue":"2","key":"1970_CR30","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/0020-7292(93)90626-8","volume":"42","author":"AK Dewan","year":"1993","unstructured":"Dewan AK, Mohan GM, Ravi R (1993) Intravesical formalin for hemorrhagic cystitis following irradiation of cancer of the cervix. Int J Gynaecol Obstet 42(2):131\u2013135","journal-title":"Int J Gynaecol Obstet"},{"issue":"5","key":"1970_CR31","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1111\/j.1442-2042.2005.01074.x","volume":"12","author":"E De Berardinis","year":"2005","unstructured":"De Berardinis E, Vicini P, Salvatori F, Sciarra A, Gentile V, Di Silverio F (2005) Superselective embolization of bladder arteries in the treatment of intractable bladder haemorrhage. Int J Urol 12(5):503\u2013505. \n                    https:\/\/doi.org\/10.1111\/j.1442-2042.2005.01074.x","journal-title":"Int J Urol"},{"issue":"1","key":"1970_CR32","first-page":"10","volume":"75","author":"C Bondavalli","year":"2003","unstructured":"Bondavalli C, Dall\u2019Oglio B, Schiavon L, Luciano M, Guatelli S, Parma P, Galletta V (2003) Complications of urinary diversion after radiotherapy. Arch Ital Urol Androl 75(1):10\u201313","journal-title":"Arch Ital Urol Androl"},{"issue":"2","key":"1970_CR33","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/j.juro.2006.03.056","volume":"176","author":"T Fazili","year":"2006","unstructured":"Fazili T, Bhat TR, Masood S, Palmer JH, Mufti GR (2006) Fate of the leftover bladder after supravesical urinary diversion for benign disease. J Urol 176(2):620\u2013621. \n                    https:\/\/doi.org\/10.1016\/j.juro.2006.03.056","journal-title":"J Urol"},{"key":"1970_CR34","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005493.pub3","author":"JB Duthie","year":"2011","unstructured":"Duthie JB, Vincent M, Herbison GP, Wilson DI, Wilson D (2011) Botulinum toxin injections for adults with overactive bladder syndrome. Cochrane Database Syst Rev. \n                    https:\/\/doi.org\/10.1002\/14651858.CD005493.pub3","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"1970_CR35","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.eururo.2008.05.007","volume":"56","author":"YC Chuang","year":"2009","unstructured":"Chuang YC, Yoshimura N, Huang CC, Wu M, Chiang PH, Chancellor MB (2009) Intravesical botulinum toxin A administration inhibits COX-2 and EP4 expression and suppresses bladder hyperactivity in cyclophosphamide-induced cystitis in rats. Eur Urol 56(1):159\u2013166. \n                    https:\/\/doi.org\/10.1016\/j.eururo.2008.05.007","journal-title":"Eur Urol"},{"issue":"3","key":"1970_CR36","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/j.urology.2011.03.070","volume":"78","author":"US Ha","year":"2011","unstructured":"Ha US, Park EY, Kim JC (2011) Effect of botulinum toxin on expression of nerve growth factor and transient receptor potential vanilloid 1 in urothelium and detrusor muscle of rats with bladder outlet obstruction-induced detrusor overactivity. Urology 78(3):721 e721-721 e726. \n                    https:\/\/doi.org\/10.1016\/j.urology.2011.03.070","journal-title":"Urology"},{"issue":"6","key":"1970_CR37","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1111\/j.1464-410X.2008.07740.x","volume":"102","author":"YC Chuang","year":"2008","unstructured":"Chuang YC, Kim DK, Chiang PH, Chancellor MB (2008) Bladder botulinum toxin A injection can benefit patients with radiation and chemical cystitis. BJU Int 102(6):704\u2013706. \n                    https:\/\/doi.org\/10.1111\/j.1464-410X.2008.07740.x","journal-title":"BJU Int"},{"issue":"10","key":"1970_CR38","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1007\/s11255-015-1098-6","volume":"47","author":"CN Dave","year":"2015","unstructured":"Dave CN, Chaus F, Chancellor MB, Lajness M, Peters KM (2015) Innovative use of intravesical tacrolimus for hemorrhagic radiation cystitis. Int Urol Nephrol 47(10):1679\u20131681. \n                    https:\/\/doi.org\/10.1007\/s11255-015-1098-6","journal-title":"Int Urol Nephrol"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11255-018-1970-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-018-1970-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-018-1970-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,13]],"date-time":"2020-05-13T20:43:50Z","timestamp":1589402630000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11255-018-1970-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,21]]},"references-count":38,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["1970"],"URL":"https:\/\/doi.org\/10.1007\/s11255-018-1970-2","relation":{},"ISSN":["0301-1623","1573-2584"],"issn-type":[{"value":"0301-1623","type":"print"},{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,21]]},"assertion":[{"value":"13 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Dr. Chancellor is the founder and Chief Scientific Officer of Lipella Pharmaceuticals, Inc. The remaining authors declare that they have no relevant conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}